Published January 26, 2012 | Version v1
Journal article

Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis

  • 1. Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE 19803 (United States)
  • 2. Nemours/Alfred I. duPont Hospital for Children, Rockland Center I, 1701 Rockland Road, Wilmington, DE 19803 (United States)

Description

Curcumin (diferuloylmethane), the yellow pigment in the Asian spice turmeric, is a hydrophobic polyphenol from the rhizome of Curcuma longa. Because of its chemopreventive and chemotherapeutic potential with no discernable side effects, it has become one of the major natural agents being developed for cancer therapy. Accumulating evidence suggests that curcumin induces cell death through activation of apoptotic pathways and inhibition of cell growth and proliferation. The mitotic checkpoint, or spindle assembly checkpoint (SAC), is the major cell cycle control mechanism to delay the onset of anaphase during mitosis. One of the key regulators of the SAC is the anaphase promoting complex/cyclosome (APC/C) which ubiquitinates cyclin B and securin and targets them for proteolysis. Because APC/C not only ensures cell cycle arrest upon spindle disruption but also promotes cell death in response to prolonged mitotic arrest, it has become an attractive drug target in cancer therapy. Cell cycle profiles were determined in control and curcumin-treated medulloblastoma and various other cancer cell lines. Pull-down assays were used to confirm curcumin binding. APC/C activity was determined using an in vitro APC activity assay. We identified Cdc27/APC3, a component of the APC/C, as a novel molecular target of curcumin and showed that curcumin binds to and crosslinks Cdc27 to affect APC/C function. We further provide evidence that curcumin preferably induces apoptosis in cells expressing phosphorylated Cdc27 usually found in highly proliferating cells. We report that curcumin directly targets the SAC to induce apoptosis preferably in cells with high levels of phosphorylated Cdc27. Our studies provide a possible molecular mechanism why curcumin induces apoptosis preferentially in cancer cells and suggest that phosphorylation of Cdc27 could be used as a biomarker to predict the therapeutic response of cancer cells to curcumin

Availability note (English)

Available from http://dx.doi.org/10.1186/1471-2407-12-44; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296673

Additional details

Publishing Information

Journal Title
BMC cancer (Online)
Journal Volume
12
Journal Page Range
p. 44
ISSN
1471-2407

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46102723
Subject category
S60: APPLIED LIFE SCIENCES; S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
APOPTOSIS; CELL CYCLE; CURCUMIN; DRUGS; IN VITRO; INHIBITION; MITOSIS; NEOPLASMS; PHOSPHORYLATION; PIGMENTS; PROTEINS; SIDE EFFECTS; SPICES; THERAPY
Descriptors DEC
AROMATICS; CELL DIVISION; CHEMICAL REACTIONS; DISEASES; DYES; ETHERS; HYDROXY COMPOUNDS; KETONES; MEDICINE; ORGANIC COMPOUNDS; ORGANIC OXYGEN COMPOUNDS; PHENOLS; POLYPHENOLS

Optional Information

Copyright
Copyright (c)2012 Lee and Langhans
Notes
PMCID: PMC3296673; PUBLISHER-ID: 1471-2407-12-44; PMID: 22280307; OAI: oai:pubmedcentral.nih.gov:3296673; licensee BioMed Central Ltd.